Deconstructing Maternal Burdens: Doulas and the Community Unite for Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age15-49
SponsorUniversity of Florida

About this trial

This study is a randomized controlled trial comparing two models of doula support for pregnant individuals enrolled in Medicaid: an enhanced doula support model, in which support starts earlier in pregnancy, occurs more frequently, and continues through the first year after birth, versus the standard doula care currently covered by Medicaid in Florida.

The study also builds the doula workforce needed to sustain this model of care, training doulas to become eligible to bill Medicaid for their services.

The primary goal is to determine whether the enhanced doula model results in significantly lower rates of perinatal depressive and anxiety symptoms compared to standard doula support, while gathering data on real-world implementation. The study also evaluates the effectiveness of Medicaid-covered doula services more broadly, with findings intended to inform state-level policy on Medicaid reimbursement and the extension of doula services into the postpartum period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

15-49 years old

14-28 weeks pregnant

Medicaid Eligible

Resides in North Central Florida

Disqualifiers

Severe physical or mental health conditions that Interfere with participation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Doula

    Other intervention

    Enhanced doula support in the post-partum period.

  • Standard (non-enhanced) Medicaid doula support

    Other intervention

    Standard (non-enhanced) Medicaid doula support

Treatment groups

516 Participants
are divided into 2 treatment groups
Group A: Enhanced Doula SupportActive comparator 1 intervention
Group B: Standard Medicaid Doula SupportOther 1 intervention

Trial outcomes

Primary outcomes

1

Evaluating the Effectiveness of UNITE Intervention

The primary outcome is a composite measure of perinatal depressive and/or anxiety symptoms. Depressive symptoms will be assessed using the Edinburgh Postnatal Depression Scale (EPDS), with a score greater than 9 indicating clinically significant symptoms; the EPDS ranges from 0 to 30, with higher scores indicating greater severity of depressive symptoms. As well as the Generalized Anxiety Disorder 7-item Scale (GAD-7), ranges from 0 to 21, with higher scores indicating greater severity of anxiety symptoms.

Time frame
4-6 weeks postpartum

Secondary outcomes

1

Perinatal Depressive Symptoms

Depressive symptoms will be assessed using the Edinburgh Postnatal Depression Scale (EPDS), the EPDS ranges from 0 to 30, with higher scores indicating greater severity of depressive symptoms. Longitudinal models will allow comparison of trends over time in mean depressive symptom scores and inferences at specific time points.

Time frame
Baseline (14-28 weeks gestation), 32-36 weeks gestation, 4-6 weeks postpartum, 3 months (±2 weeks) postpartum, and 9-12 months postpartum
2

Perinatal Anxiety Symptoms

Anxiety symptoms will be assessed using the Generalized Anxiety Disorder 7-item Scale (GAD-7), which ranges from 0 to 21, with higher scores indicating greater severity of anxiety symptoms. Longitudinal models will allow comparison of trends over time in mean anxiety scores and inferences at specific time points.

Time frame
Baseline (14-28 weeks gestation), 32-36 weeks gestation, 4-6 weeks postpartum, 3 months (±2 weeks) postpartum, and 9-12 months postpartum
3

Perceived Stress

Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS-10), administered at all time points. The PSS-10 ranges from 0 to 40, with higher scores indicating greater perceived stress.

Time frame
Baseline (14-28 weeks gestation), 32-36 weeks gestation, 4-6 weeks postpartum, 3 months (±2 weeks) postpartum, and 9-12 months postpartum
4

Social Support

The Medical Outcomes Study Social Support Survey (MOS-SSS) is a 19-item self-administered survey, with items rated on a 5-point scale. Scores are transformed to a 0-to-100 scale, where higher scores represent higher, better perceived social support.

Time frame
Baseline (14-28 weeks gestation), 32-36 weeks gestation, 4-6 weeks postpartum, 3 months (±2 weeks) postpartum, and 9-12 months postpartum

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Florida

Lead sponsor

National Institute of Nursing Research (NINR)

Collaborator